MedTrace Logo

Whole Body Vibration Training Among Older People Using Sheltered Housing

NCT01523600 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2016-05-11

No results posted yet for this study

Summary

The purpose of this randomised (double-blind) controlled exercise intervention trial is to determine whether the whole body vibration (WBV) training can effectively improve physical functioning of older people living in or regularly using services of sheltered housing, reduce their fear of falling, and prevent falling. The study comprises a 10-week training period and a 10-month follow-up period.

Conditions

  • Falls
  • Physical Performance
  • Fear of Falling

Interventions

BEHAVIORAL

Whole body vibration training

The intervention comprises a 10-week individually supervised, progressive WBV training done twice a week on a side-alternating device with simultaneous body transferring and slight squatting exercises. At the week one, the duration of a single training bout is 1 x 1 min, and the number of 1 min bouts is weekly increased by one until five bouts is reached. During weeks 4 - 10, the training comprises 5 x 1 min bouts with 1 min rest periods between. During weeks 1 to 3, vibration frequencies are 12 and 18 Hz, which are used alternately. Thereafter, also 26 Hz may be used instead of 18 Hz. In addition, the amplitude of vibration is increased progressively according to a specified protocol. A detailed training diary is kept.

BEHAVIORAL

Wellness group

The intervention comprises a 10-week supervised group training done once a week with the focus on stretching and flexibility exercises done mostly in a sitting position. The duration of a single training session is 45 minutes. A training diary is kept.

Sponsors & Collaborators

  • Ministry of Education and Culture, Finland

    collaborator OTHER

  • Pirkanmaa Hospital District

    collaborator UNKNOWN

  • UKK Institute

    lead OTHER

Principal Investigators

  • Harri Sievanen, ScD · The UKK Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-03-31
Completion
2016-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01523600 on ClinicalTrials.gov